All Stories

  1. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate

    Article • Parasitology, July 2017, Cambridge University Press

    Dr Anuradha Dube

  2. Management of visceral leishmaniasis with therapeutic vaccines

    Article • Vaccine Development and Therapy, September 2016, Dove Medical Press

    Dr Anuradha Dube, Dr Sumit Joshi

  3. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis

    Article • Clinical & Experimental Immunology, April 2016, Wiley

    Dr Anuradha Dube

  4. Immunostimulatory potential and proteome profiling ofLeishmania donovanisoluble exogenous antigens

    Article • Parasite Immunology, June 2015, Wiley

    Dr Anuradha Dube

  5. Immunological consequences of stress-related proteins – cytosolic tryparedoxin peroxidase and chaperonin TCP20 – identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis

    Article • Parasitology, December 2014, Cambridge University Press

    Dr Anuradha Dube

  6. Efficacy ofWithania somniferachemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis

    Article • Parasite Immunology, May 2014, Wiley

    Dr Anuradha Dube

  7. Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance

    Article • Antimicrobial Agents and Chemotherapy, March 2014, ASM Journals

    Dr Anuradha Dube

  8. Mass spectrometry-based proteomic analysis ofLeishmania donovanisoluble proteins in Indian clinical isolate

    Article • Pathogens and Disease, November 2013, Oxford University Press (OUP)

    Dr Anuradha Dube